Skip to content

D&A at other companies

RadNet logo
RadNetRDNT
$44.97M+26.7%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$78M+18.2%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$22.68M+66.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$173.3M+3.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$147M+5.0%
Opko Health logo
Opko HealthOPK
$22.2M-5.5%

Other financials

Income statement

See full
Revenue$252.5M+3.1%
Operating income$19.4M-24.0%
Net income$1.7M+122%
EPS (diluted)$0.02+118%

Balance sheet

See full
Cash & equivalents$51.2M
Total debt$965.8M
Total equity$599.6M+272%
Total assets$1.8B

Cash flow

See full
Operating cash flow$2.9M+121%
CapEx$5.3M+431%
Free cash flow-$2.4M+84.1%

Valuation

See full
Market cap$958.89M-45.3%
Enterprise value$1.87B

Returns & leverage

See full
Debt / equity1.6×
Current ratio1.4×

Where this comes from

Reported directly by Lumexa Imaging Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Lumexa Imaging Holdings, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lumexa Imaging Holdings, Inc. 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lumexa Imaging Holdings, Inc. 's D&A?
Lumexa Imaging Holdings, Inc. (LMRI) reported D&A of $9.92M in Q1 2026.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.